% | $
Quotes you view appear here for quick access.

Enanta Pharmaceuticals, Inc. Message Board

  • kris_kade kris_kade Nov 17, 2013 8:18 PM Flag

    Excellent long term hold with $60 conservative price target

    $60 is based on sales that are conservative as well. This does not even include their MRSA fighting new class of antibiotics !

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Agree. More if their MRSA or any of preclinical hcv inhibitor works.

      BTW, for MRSA, just not sure about the market potential. Do you have any research on it?

      • 1 Reply to hufrd
      • MRSA stands for methicillin resistant Staphylococcus aureus, and is responsible for about 20,000 annual deaths and over 300,000 hospitalizations, and over $4 billion spent annually on fighting it. It is extremely resistant to a host of antibiotics and its resistance is increasing. Hospitals are literally running out of antibiotic options to treat this deadly infection. It's an epidemic in hospital and nursing home environments. A highly effective new antibiotic that is priced right will be an instant blockbuster drug.

        Sentiment: Strong Buy

22.38+0.01(+0.04%)Aug 26 4:00 PMEDT